Adipotide: Precision-Targeted Peptide for Fat Cell Research
Discover the revolutionary peptide targeting white adipose tissue for advanced obesity studies.
Get a Quote & SampleProduct Core Value
Adipotide
Adipotide is a first-in-class targeted compound that induces programmed cell death (apoptosis) specifically in white adipose tissue. Its unique FTPP homing sequence binds to prohibitin receptors on fat cell vasculature, making it a revolutionary tool for obesity mechanism studies.
- Targeted fat reduction: Adipotide selectively disrupts the blood supply to adipose tissue, a key aspect of understanding targeted fat reduction peptide applications.
- Metabolic disease models: It aids in studies of obesity-linked conditions like type 2 diabetes, leveraging its unique adipotide peptide mechanism of action.
- Prohibitin receptor targeting: The peptide's specificity for prohibitin receptors on fat cell vasculature is crucial for its efficacy in research.
- Weight management research: Researchers explore adipotide for weight loss in various preclinical settings.
Key Advantages
Precise Targeting
Adipotide's ability to specifically target fat cell vasculature offers unparalleled precision in adipotide clinical trials and experimental research.
Mechanism Validation
The validated FTPP peptide research demonstrates a clear pathway for disrupting fat cell blood supply and inducing apoptosis.
Preclinical Efficacy
Significant weight loss and metabolic improvements observed in animal models highlight Adipotide's potential as a research tool.
Key Applications
Obesity Mechanism Studies
Investigating the intricate processes behind obesity through a compound with a well-defined adipotide peptide mechanism of action.
Metabolic Disease Research
Understanding and potentially developing treatments for metabolic disorders by studying Adipotide's impact on fat cells and insulin sensitivity.
Targeted Fat Reduction
Exploring novel approaches for targeted fat reduction peptide applications in preclinical research settings.
Pharmaceutical Intermediate Use
Serving as a critical intermediate in the development of new pharmaceutical agents for weight management and related conditions.